Progressive Care (RXMD)
OTHER OTC:RXMD
US Market

Progressive Care (RXMD) Income Statement

60 Followers

Progressive Care Income Statement

Last quarter (Q3 2023), Progressive Care's total revenue was $12.36M, an increase of 21.84% from the same quarter last year. In Q3, Progressive Care's net income was $-1.37M. See Progressive Care’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 45.74M-$ 40.60M$ 38.85M$ 38.94M$ 32.63M
Cost of Revenue
$ -6.97M-$ 30.90M$ 28.68M$ 29.98M$ 24.66M
Gross Profit
$ 30.12M-$ 9.70M$ 10.17M$ 8.96M$ 7.97M
Operating Expense
$ -8.12M-$ 12.28M$ 11.21M$ 9.98M$ 8.76M
Operating Income
$ 21.65M-$ -2.58M$ -1.04M$ -1.02M$ -794.92K
Net Non Operating Interest Income Expense
$ 7.52M-$ -713.00K$ -1.40M$ -1.70M$ -1.25M
Other Income Expense
$ 7.57M-$ 3.91M$ 2.65M$ 1.28M$ -463.40K
Pretax Income
$ -841.18K-$ -5.90M$ 217.99K$ -1.44M$ -2.50M
Tax Provision
--$ 1.00K$ 0.00$ 6.78K$ 2.69K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 21.91M-$ -6.45M$ 217.99K$ -1.45M$ -2.51M
Basic EPS
$ -3.52-$ -2.21$ 0.08$ >-0.01$ >-0.01
Diluted EPS
$ -3.52-$ -2.21$ 0.07$ >-0.01$ >-0.01
Basic Average Shares
$ 16.87M-$ 2.91M$ 2.60M$ 462.19M$ 431.00M
Diluted Average Shares
$ 16.87M-$ 2.91M$ 3.09M$ 462.19M$ 431.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -23.60M-$ 43.18M$ 39.89M$ 39.95M$ 33.42M
Net Income From Continuing And Discontinued Operation
$ 21.91M-$ -5.90M$ 217.99K$ -1.45M$ -2.51M
Normalized Income
$ -4.56M--$ -2.43M$ -2.38M$ -2.17M
Interest Expense
---$ 1.40M$ 1.70M$ 1.25M
EBIT
$ -8.33M-$ -6.40M$ 1.61M$ 259.83K$ -1.26M
EBITDA
$ -2.81M-$ -5.60M$ 2.18M$ 1.11M$ -799.98K
Currency in USD

Progressive Care Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis